tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market
Advertisement

Immuneering (IMRX) Technical Analysis

Compare
424 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immuneering’s (IMRX) Moving Averages Convergence Divergence (MACD) indicator is 0.41, suggesting Immuneering is a Buy.
Immuneering’s (IMRX) 20-Day exponential moving average is 3.82, while Immuneering’s (IMRX) share price is $4, making it a Buy.
Immuneering’s (IMRX) 50-Day exponential moving average is 3.06, while Immuneering’s (IMRX) share price is $4, making it a Buy.

Immuneering (IMRX) Pivot Points

Jul 26, 2025, 12:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.28
3.68
3.89
4.29
4.50
4.90
5.11
Fibonacci
3.68
3.91
4.06
4.29
4.52
4.67
4.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immuneering (IMRX) Moving Averages

Jul 26, 2025, 12:21 AM
Period
Simple
Exponential
MA5
4.14Sell
4.11Sell
MA10
4.17Sell
4.09Sell
MA20
3.96Buy
3.82Buy
MA50
2.74Buy
3.06Buy
MA100
2.09Buy
2.50Buy
MA200
2.05Buy
2.21Buy
Immuneering’s (IMRX) 10-Day exponential moving average is 4.09, while Immuneering’s (IMRX) share price is $4, making it a Sell.
Immuneering’s (IMRX) 100-Day exponential moving average is 2.50, while Immuneering’s (IMRX) share price is $4, making it a Buy.
Immuneering’s (IMRX) stock price is $4 and Immuneering’s (IMRX) 50-day simple moving average is 2.74, creating a Buy signal.
Immuneering’s (IMRX) stock price is $4 and Immuneering’s (IMRX) 100-day simple moving average is 2.09, creating a Buy signal.
Immuneering’s (IMRX) stock price is $4 and Immuneering’s (IMRX) 200-day simple moving average is 2.05, creating a Buy signal.

Immuneering (IMRX) Technical Indicators

Jul 26, 2025, 12:21 AM
Name
Value
Implied Action
RSI (14)
58.63
Neutral
STOCH (9,6)
34.96
Neutral
STOCHRSI (14)
57.70
Neutral
MACD (12,26)
0.41
Buy
ADX (14)
45.54
Neutral
Williams %R
-54.73
Buy
CCI (14)
27.51
Neutral
ATR (14)
0.38
-
Ultimate Oscillator
46.63
Neutral
ROC
15.94
Buy
Immuneering’s (IMRX) Relative Strength Index (RSI) is 58.63, creating a Neutral signal.
Immuneering’s (IMRX) Trend Strength Indicator (ADX) is 45.54, creating a Neutral signal.
Immuneering’s (IMRX) Commodity Channel Index (CCI) is 27.51, creating a Neutral signal.
Immuneering’s (IMRX) Price Rate of Change (ROC) is 15.94, creating a Buy signal.

FAQ

Is IMRX a Buy, Hold, or Sell?
Based on IMRX’s technical indicators, IMRX is a Buy.
    What is IMRX’s RSI (14)?
    IMRX’s RSI (14) is 58.63, which suggests IMRX is a Neutral.
      What is IMRX’s MACD?
      IMRX’s MACD is 0.41, which suggests IMRX is a Buy.
        What is IMRX’s 5-day moving average?
        IMRX’s 5-day moving average is 4.14, which suggests IMRX is a Sell.
          What is IMRX’s 20-day moving average?
          IMRX 20-day moving average is 3.96, which suggests IMRX is a Buy.
            What is IMRX’s 50-day moving average?
            IMRX’s 50-day moving average is 2.74, which suggests IMRX is a Buy.
              What is IMRX’s 200-day moving average?
              IMRX’s 200-day moving average is 2.05, which suggests IMRX is a Buy.
                What is IMRX’s Williams % R (14)?
                IMRX’s Williams % R (14) is -54.73, which suggests IMRX is a Buy.
                  What is IMRX’s CCI (14)?
                  IMRX’s CCI (14) is 27.51, which suggests IMRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis